Melanoma gp100 Antikörper (AA 25-467)

Produktnummer ABIN7159229

Produktdetails anti-Melanoma gp100 Antikörper

Target: Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))

Bindungsspezifität: AA 25-467

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Melanoma gp100 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), Western Blotting (WB), ELISA

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Melanocyte protein PMEL protein (25-467AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:1000-1:5000, IHC:1:200-1:500,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu Melanoma gp100

Target: Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))

Andere Bezeichnung: PMEL (PMEL Produkte)

Synonyme: D12S53E antikoerper, ME20 antikoerper, ME20-M antikoerper, ME20M antikoerper, P1 antikoerper, P100 antikoerper, PMEL17 antikoerper, SI antikoerper, SIL antikoerper, SILV antikoerper, gp100 antikoerper, D10H12S53E antikoerper, D12S53Eh antikoerper, Pmel17 antikoerper, Si antikoerper, Silv antikoerper, gp87 antikoerper, RPE1 antikoerper, MMP115 antikoerper, silverb antikoerper, silver antikoerper, cb397 antikoerper, fdv antikoerper, pmel17 antikoerper, sb:cb397 antikoerper, silva antikoerper, wu:fc11g11 antikoerper, wu:fj24g11 antikoerper, zgc:136622 antikoerper, premelanosome protein antikoerper, premelanosome protein b antikoerper, premelanosome protein a antikoerper, PMEL antikoerper, Pmel antikoerper, pmelb antikoerper, pmela antikoerper

Hintergrund:

Background: Plays a central role in the biogenesis of melanosomes. Involved in the maturation of melanosomes from stage I to II. The transition from stage I melanosomes to stage II melanosomes involves an elongation of the vesicle, and the appearance within of distinct fibrillar structures. Release of the soluble form, ME20-S, could protect tumor cells from antibody mediated immunity.

Aliases: 95 kDa melanocyte specific secreted glycoprotein antibody, 95 kDa melanocyte-specific secreted glycoprotein antibody, D12S53E antibody, gp100 antibody, M-beta antibody, ME20 antibody, ME20 M/ME20 S antibody, ME20-M antibody, ME20-S antibody, ME20M antibody, ME20M/ME20S antibody, ME20S antibody, Melanocyte lineage specific antigen GP100 antibody, Melanocyte protein mel 17 antibody, Melanocyte protein Pmel 17 antibody, Melanocyte protein Pmel 17 precursor antibody, Melanocytes lineage-specific antigen GP100 antibody, Melanoma associated ME20 antigen antibody, Melanoma gp100 antibody, Melanoma-associated ME20 antigen antibody, Melanosomal matrix protein 17 antibody, Melanosomal matrix protein17 antibody, P1 antibody, p100 antibody, p26 antibody, PMEL 17 antibody, PMEL antibody, PMEL_HUMAN antibody, PMEL17 antibody, Premelanosome protein antibody, Secreted melanoma-associated ME20 antigen antibody, SI antibody, SIL antibody, SILV antibody, Silver (mouse homolog) like antibody, Silver homolog antibody, Silver locus protein homolog antibody, Silver, mouse, homolog of antibody

UniProt: P40967